Bio Rad Laboratories Inc/ US0905722072 /
| 2024-10-18 10:10:00 PM | Chg. +2.39 | Volume | Bid11:41:33 PM | Ask11:41:33 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 346.37USD | +0.69% | 190,992 Turnover: 27.69 mill. |
338.51Bid Size: 100 | 353.41Ask Size: 100 | 7.9 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -21.82 USD | -82.08% |
| EPS Diluted: | -21.82 USD | -82.08% |
| Revenues per Share: | 114.05 USD | -0.20% |
| Book Value per Share: | 373.19 USD | -4.83% |
| Cash Flow per Share: | 16.01 USD | 101.90% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 2,671.26 USD | -4.67% |
| Net Income: | -637.30 USD | -82.43% |
| Operating Cash Flow: | 374.90 USD | - |
| Cash and Cash Equivalents: | 403.82 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 3.04 | 2.83 |
| P/BV ratio: | 0.93 | 0.87 |
| P/CF Ratio: | 21.64 | 20.17 |
| PEG: | 0.19 | - |
| Earnings Yield: | -6.30% | -6.76% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 7.9 bill. USD | 7.56 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 22.79 mill. | |
Profitability
| Gross Profit Margin: | 53.42% |
| EBIT Margin: | 12.65% |
| Net Profit Margin: | -23.86% |
| Return on Equity: | -7.29% |
| Return on Assets: | -5.18% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.77% |
| Liquidity II / Quick Ratio: | 1.71% |
| Liquidity III / Current Ratio: | 5.83% |
| Debt / Equity Ratio: | 0.14% |
| Dynam. Debt / Equity Ratio: | 949.04% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
